New York, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Urolithiasis Management Devices Industry" - https://www.reportlinker.com/p06033203/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027. Extracorporeal Shock Wave Lithotripsy (ESWL), one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$926.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Intracorporeal Lithotripsy segment is readjusted to a revised 5.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $434.5 Million, While China is Forecast to Grow at 8.8% CAGR
The Urolithiasis Management Devices market in the U.S. is estimated at US$434.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$481.6 Million by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$311.3 Million by the year 2027.
Percutaneous Nephrolithotomy Segment to Record 5.6% CAGR
In the global Percutaneous Nephrolithotomy segment, USA, Canada, Japan, China and Europe will drive the 5.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$264.1 Million in the year 2020 will reach a projected size of US$377.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 6% CAGR through the analysis period.
Select Competitors (Total 42 Featured) -
Boston Scientific
Cook Medical
Cybersonics
Direxgroup
Dornier
Dornier
Elmed
Karl Storz
MTS Medical
Olympus
Read the full report: https://www.reportlinker.com/p06033203/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Urolithiasis Management Devices - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Urolithiasis Management
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Urolithiasis Management
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for
Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 5: World Historic Review for Extracorporeal Shock Wave
Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Extracorporeal Shock
Wave Lithotripsy (ESWL) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Intracorporeal Lithotripsy by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Intracorporeal Lithotripsy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Intracorporeal
Lithotripsy by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for
Percutaneous Nephrolithotomy by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Percutaneous
Nephrolithotomy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Percutaneous
Nephrolithotomy by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Other Treatment Types by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Other Treatment Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Other Treatment Types
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for
Hospitals & Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for
Ambulatory Surgical Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Ambulatory Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Ambulatory Surgical
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 22: World Urolithiasis Management Devices Market Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 23: USA Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 24: USA Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 25: USA 15-Year Perspective for Urolithiasis Management
Devices by Treatment Type - Percentage Breakdown of Value Sales
for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 26: USA Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 27: USA Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 28: USA 15-Year Perspective for Urolithiasis Management
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics and Ambulatory Surgical Centers for the
Years 2012, 2021 & 2027
CANADA
Table 29: Canada Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 30: Canada Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 31: Canada 15-Year Perspective for Urolithiasis
Management Devices by Treatment Type - Percentage Breakdown of
Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 32: Canada Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 33: Canada Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 34: Canada 15-Year Perspective for Urolithiasis
Management Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgical Centers
for the Years 2012, 2021 & 2027
JAPAN
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 35: Japan Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 36: Japan Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 37: Japan 15-Year Perspective for Urolithiasis Management
Devices by Treatment Type - Percentage Breakdown of Value Sales
for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 38: Japan Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 39: Japan Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 40: Japan 15-Year Perspective for Urolithiasis Management
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics and Ambulatory Surgical Centers for the
Years 2012, 2021 & 2027
CHINA
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 41: China Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 42: China Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 43: China 15-Year Perspective for Urolithiasis Management
Devices by Treatment Type - Percentage Breakdown of Value Sales
for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 44: China Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 45: China Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 46: China 15-Year Perspective for Urolithiasis Management
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics and Ambulatory Surgical Centers for the
Years 2012, 2021 & 2027
EUROPE
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 47: Europe Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 48: Europe Historic Review for Urolithiasis Management
Devices by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 49: Europe 15-Year Perspective for Urolithiasis
Management Devices by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2012, 2021 & 2027
Table 50: Europe Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 51: Europe Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 52: Europe 15-Year Perspective for Urolithiasis
Management Devices by Treatment Type - Percentage Breakdown of
Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 53: Europe Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 54: Europe Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 55: Europe 15-Year Perspective for Urolithiasis
Management Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgical Centers
for the Years 2012, 2021 & 2027
FRANCE
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2022 (E)
Table 56: France Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 57: France Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 58: France 15-Year Perspective for Urolithiasis
Management Devices by Treatment Type - Percentage Breakdown of
Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 59: France Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 60: France Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 61: France 15-Year Perspective for Urolithiasis
Management Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgical Centers
for the Years 2012, 2021 & 2027
GERMANY
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 62: Germany Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 63: Germany Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 64: Germany 15-Year Perspective for Urolithiasis
Management Devices by Treatment Type - Percentage Breakdown of
Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 65: Germany Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 66: Germany Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 67: Germany 15-Year Perspective for Urolithiasis
Management Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgical Centers
for the Years 2012, 2021 & 2027
ITALY
Table 68: Italy Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 69: Italy Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 70: Italy 15-Year Perspective for Urolithiasis Management
Devices by Treatment Type - Percentage Breakdown of Value Sales
for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 71: Italy Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 72: Italy Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 73: Italy 15-Year Perspective for Urolithiasis Management
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics and Ambulatory Surgical Centers for the
Years 2012, 2021 & 2027
UNITED KINGDOM
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2022 (E)
Table 74: UK Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 75: UK Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 76: UK 15-Year Perspective for Urolithiasis Management
Devices by Treatment Type - Percentage Breakdown of Value Sales
for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 77: UK Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 78: UK Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 79: UK 15-Year Perspective for Urolithiasis Management
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics and Ambulatory Surgical Centers for the
Years 2012, 2021 & 2027
SPAIN
Table 80: Spain Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 81: Spain Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 82: Spain 15-Year Perspective for Urolithiasis Management
Devices by Treatment Type - Percentage Breakdown of Value Sales
for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 83: Spain Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 84: Spain Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 85: Spain 15-Year Perspective for Urolithiasis Management
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics and Ambulatory Surgical Centers for the
Years 2012, 2021 & 2027
RUSSIA
Table 86: Russia Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 87: Russia Historic Review for Urolithiasis Management
Devices by Treatment Type - Extracorporeal Shock Wave
Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous
Nephrolithotomy and Other Treatment Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 88: Russia 15-Year Perspective for Urolithiasis
Management Devices by Treatment Type - Percentage Breakdown of
Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 89: Russia Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 90: Russia Historic Review for Urolithiasis Management
Devices by End-Use - Hospitals & Clinics and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 91: Russia 15-Year Perspective for Urolithiasis
Management Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgical Centers
for the Years 2012, 2021 & 2027
REST OF EUROPE
Table 92: Rest of Europe Recent Past, Current & Future Analysis
for Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 93: Rest of Europe Historic Review for Urolithiasis
Management Devices by Treatment Type - Extracorporeal Shock
Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy,
Percutaneous Nephrolithotomy and Other Treatment Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 94: Rest of Europe 15-Year Perspective for Urolithiasis
Management Devices by Treatment Type - Percentage Breakdown of
Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 95: Rest of Europe Recent Past, Current & Future Analysis
for Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 96: Rest of Europe Historic Review for Urolithiasis
Management Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgical Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 97: Rest of Europe 15-Year Perspective for Urolithiasis
Management Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgical Centers
for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Asia-Pacific for
2022 (E)
Table 98: Asia-Pacific Recent Past, Current & Future Analysis
for Urolithiasis Management Devices by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2020 through 2027 and % CAGR
Table 99: Asia-Pacific Historic Review for Urolithiasis
Management Devices by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 100: Asia-Pacific 15-Year Perspective for Urolithiasis
Management Devices by Geographic Region - Percentage Breakdown
of Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2021 & 2027
Table 101: Asia-Pacific Recent Past, Current & Future Analysis
for Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 102: Asia-Pacific Historic Review for Urolithiasis
Management Devices by Treatment Type - Extracorporeal Shock
Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy,
Percutaneous Nephrolithotomy and Other Treatment Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 103: Asia-Pacific 15-Year Perspective for Urolithiasis
Management Devices by Treatment Type - Percentage Breakdown of
Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL),
Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and
Other Treatment Types for the Years 2012, 2021 & 2027
Table 104: Asia-Pacific Recent Past, Current & Future Analysis
for Urolithiasis Management Devices by End-Use - Hospitals &
Clinics and Ambulatory Surgical Centers - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 105: Asia-Pacific Historic Review for Urolithiasis
Management Devices by End-Use - Hospitals & Clinics and
Ambulatory Surgical Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 106: Asia-Pacific 15-Year Perspective for Urolithiasis
Management Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics and Ambulatory Surgical Centers
for the Years 2012, 2021 & 2027
AUSTRALIA
Urolithiasis Management Devices Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Australia for 2022
(E)
Table 107: Australia Recent Past, Current & Future Analysis for
Urolithiasis Management Devices by Treatment Type -
Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal
Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 108: Australia Historic Review for Urolithiasis
Management Devices by Treatment Type - Extracorporeal Shock
Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy,
Percutaneous Nephrolithotomy and Other Treatment Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 109: Australia 15-Year Perspective for Urolithiasis
Management Devices by Treatment Type - Percentage Breakdown of
Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL),
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033203/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
